BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 26186556)

  • 1. Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer.
    Inhestern J; Oertel K; Stemmann V; Schmalenberg H; Dietz A; Rotter N; Veit J; Görner M; Sudhoff H; Junghanß C; Wittekindt C; Pachmann K; Guntinas-Lichius O
    PLoS One; 2015; 10(7):e0132901. PubMed ID: 26186556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1).
    Inhestern J; Schmalenberg H; Dietz A; Rotter N; Maschmeyer G; Jungehülsing M; Grosse-Thie C; Kuhnt T; Görner M; Sudhoff H; Wittekindt C; Guntinas-Lichius O
    Ann Oncol; 2017 Aug; 28(8):1917-1922. PubMed ID: 28498880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1).
    Oertel K; Spiegel K; Schmalenberg H; Dietz A; Maschmeyer G; Kuhnt T; Sudhoff H; Wendt TG; Guntinas-Lichius O
    BMC Cancer; 2012 Oct; 12():483. PubMed ID: 23083061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.
    Zhong LP; Zhang CP; Ren GX; Guo W; William WN; Sun J; Zhu HG; Tu WY; Li J; Cai YL; Wang LZ; Fan XD; Wang ZH; Hu YJ; Ji T; Yang WJ; Ye WM; Li J; He Y; Wang YA; Xu LQ; Wang BS; Kies MS; Lee JJ; Myers JN; Zhang ZY
    J Clin Oncol; 2013 Feb; 31(6):744-51. PubMed ID: 23129742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel - three year results of a pilot study.
    Kovács AF; Schiemann M; Turowski B
    J Craniomaxillofac Surg; 2002 Apr; 30(2):112-20. PubMed ID: 12069515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma.
    Zhong LP; Zhang CP; Ren GX; Guo W; William WN; Hong CS; Sun J; Zhu HG; Tu WY; Li J; Cai YL; Yin QM; Wang LZ; Wang ZH; Hu YJ; Ji T; Yang WJ; Ye WM; Li J; He Y; Wang YA; Xu LQ; Zhuang Z; Lee JJ; Myers JN; Zhang ZY
    Oncotarget; 2015 Jul; 6(21):18707-14. PubMed ID: 26124084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative chemotherapy with cisplatin and 5-fluorouracil in cancer of the oral cavity and the oropharynx--long-term results.
    Kovács AF; Ghahremani MT; Stefenelli U; Bitter K
    J Chemother; 2003 Oct; 15(5):495-502. PubMed ID: 14598943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation grade.
    Zhu DW; Liu Y; Yang X; Yang CZ; Ma J; Yang X; Qiao JK; Wang LZ; Li J; Zhang CP; Zhang ZY; Zhong LP
    BMC Cancer; 2013 Jun; 13():301. PubMed ID: 23786757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of a surgical method in combined and complex treatment of patients with squamous cell oral and oropharyngeal cancer].
    Vikhlianov IV; Shoĭket IaN; Lazarev AF
    Khirurgiia (Mosk); 2007; (1):55-8. PubMed ID: 17426691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
    Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
    Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential therapy of advanced buccal mucosa squamous cell carcinoma: three-year outcome.
    Lyu J; Li C; Wu Y; Wang R; Ren G; Guo W
    J Oral Maxillofac Surg; 2014 Mar; 72(3):606-10. PubMed ID: 24342583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
    Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
    Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients with pathologic T0N+ oral and oropharyngeal cancer after neoadjuvant therapy and surgery: the minority report.
    Perisanidis C; Sulzbacher I; Mittlböck M; Mitchell D; Czembirek C; Seemann R; Ewers R; Schopper C; Selzer E
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Mar; 115(3):293-8. PubMed ID: 22939322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
    Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI
    Cochrane Database Syst Rev; 2011 Apr; (4):CD006386. PubMed ID: 21491393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Early Recurrence Prior to Planned Postoperative Radiation Therapy for Oral Cavity Squamous Cell Carcinoma and Outcomes Following Salvage Intensified Radiation Therapy.
    Hosni A; Huang SH; Chiu K; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; O'Sullivan B; Ringash J; Waldron J; Spreafico A; Yu E; de Almeida JR; Monteiro E; Chepeha DB; Irish JC; Goldstein DP; Hope A
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):363-373. PubMed ID: 30244160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma.
    Yang CZ; Ma J; Zhu DW; Liu Y; Montgomery B; Wang LZ; Li J; Zhang ZY; Zhang CP; Zhong LP
    Ann Oncol; 2014 Jun; 25(6):1215-22. PubMed ID: 24669014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up).
    Mohr C; Bohndorf W; Carstens J; Härle F; Hausamen JE; Hirche H; Kimmig H; Kutzner J; Mühling J; Reuther J
    Int J Oral Maxillofac Surg; 1994 Jun; 23(3):140-8. PubMed ID: 7930766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current role for induction chemotherapy in head and neck tumors].
    Dietz A; Keilholz U; Werner J; Hagen R; Flentje M; Iro H
    Laryngorhinootologie; 2008 Apr; 87(4):237-43; discussion 244. PubMed ID: 18365986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral and oropharyngeal cancer in the West of Scotland-long-term outcome data of a prospective audit 1999-2001.
    McMahon JD; Robertson GA; Liew C; McManners J; Mackenzie FR; Hislop WS; Morley SE; Devine J; Carton AT; Harvey S; Hunter K; Robertson AG
    Br J Oral Maxillofac Surg; 2011 Mar; 49(2):92-8. PubMed ID: 20646803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Salvage surgery for radiation failure in oral, oropharyngeal, and hypopharyngeal squamous cell carcinoma].
    Suzuki M; Terada A; Ogawa T; Suzuki H; Hasegawa Y
    Nihon Jibiinkoka Gakkai Kaiho; 2007 Jun; 110(6):461-5. PubMed ID: 17633115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.